1. Home
  2. PBI vs NVCR Comparison

PBI vs NVCR Comparison

Compare PBI & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pitney Bowes Inc.

PBI

Pitney Bowes Inc.

HOLD

Current Price

$17.59

Market Cap

2.4B

Sector

Miscellaneous

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$15.06

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBI
NVCR
Founded
1920
2000
Country
United States
Switzerland
Employees
6600
N/A
Industry
Office Equipment/Supplies/Services
Medical/Dental Instruments
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
PBI
NVCR
Price
$17.59
$15.06
Analyst Decision
Hold
Buy
Analyst Count
3
6
Target Price
$13.00
$28.08
AVG Volume (30 Days)
1.7M
1.8M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
2.29%
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
N/A
$655,353,000.00
Revenue This Year
N/A
$7.72
Revenue Next Year
N/A
$6.74
P/E Ratio
$13.24
N/A
Revenue Growth
N/A
8.28
52 Week Low
$8.95
$9.82
52 Week High
$19.07
$21.45

Technical Indicators

Market Signals
Indicator
PBI
NVCR
Relative Strength Index (RSI) 45.73 44.54
Support Level $16.69 $14.85
Resistance Level $18.51 $15.46
Average True Range (ATR) 0.63 1.12
MACD -0.12 -0.16
Stochastic Oscillator 15.57 3.67

Price Performance

Historical Comparison
PBI
NVCR

About PBI Pitney Bowes Inc.

Pitney Bowes Inc is a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the globe. The company's reportable segments are SendTech Solutions and Presort Services. SendTech Solutions includes the revenue and related expenses from physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications to help simplify and save on the sending, tracking and receiving of letters, parcels and flats. Presort Services includes the revenue and related expenses from sortation services to qualify large volumes of First Class Mail, Marketing Mail and Marketing Mail Flats/Bound Printed Matter for postal work sharing discounts. It derives maximum revenue from SendTech Solutions.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: